首页> 外文期刊>Frontiers in Cell and Developmental Biology >Thyroxine transfer from cerebrospinal fluid into choroid plexus and brain is affected by brefeldin A, low sodium, BCH, and phloretin, in ventriculo-cisternal perfused rabbits
【24h】

Thyroxine transfer from cerebrospinal fluid into choroid plexus and brain is affected by brefeldin A, low sodium, BCH, and phloretin, in ventriculo-cisternal perfused rabbits

机译:甲状腺素从脑脊液转移到脉络丛和大脑中受到布雷菲德菌素A,低钠,BCH和促肾上腺皮质激素的影响,在脑室-脑池灌注兔中

获取原文
获取外文期刊封面目录资料

摘要

Thyroxine (T4) hormone is synthesized by the thyroid gland and then released into the systemic circulation where it binds to a number of proteins. Dysfunction in T4 transport mechanisms has been demonstrated in multiple central nervous system (CNS) diseases including Alzheimer’s disease. In the presence of different compounds that inhibit potential T4 transport mechanisms, this study investigated the transfer of T4 from cerebrospinal fluid (CSF) into Choroid Plexus (CP) and other brain tissues. The compounds used were brefeldin A, low sodium artificial CSF (aCSF), BCH, phloretin, and taurocholate (TA). Radiolabeled T4 (125I-T4) was perfused continuously into the CSF and was assessed in several brain compartments with reference molecule 14C-mannitol and blue dextran, using the in vivo ventriculo-cisternal perfusion (V-C) technique in the rabbit. The aCSF containing the drug of interest was infused after one hour of perfusion. Drugs were applied independently to the aCSF after one hour of control perfusion. Of interest, in presence of low sodium or BCH, the percentage recovery of 125I-T4, was increased compared to controls, with concomitant increase in T4 clearance. Conversely, brefeldin A, phloretin and TA did not exert any significant effect on the recovery and clearance of 125I-T4 assessed in aCSF. On the other hand, the uptake of 125I-T4 into CP was raised by 18 fold compared to controls in the presence of brefeldin A. In addition, low sodium, BCH, or phloretin alone, enhanced the uptake of 125I-T4 by almost 3 fold, whereas TA did not show any significant effect. Finally, the uptake and distribution of 125I-T4 into other brain regions including ependymal region (ER) and caudate putamen (CAP) were significantly higher than in controls. Our study suggests the involvement of different mechanisms for the transfer of 125I-T4 from CSF into CP and other brain regions. This transfer may implicate sodium-dependent mechanisms, amino acid ‘L’ system, or organic anion transporting polypeptide (OATP).
机译:甲状腺素(T4)激素是由甲状腺合成的,然后释放到体循环中,与多种蛋白质结合。在包括阿尔茨海默氏病在内的多种中枢神经系统(CNS)疾病中已证明T4转运机制功能异常。在存在抑制潜在T4转运机制的不同化合物的情况下,本研究调查了T4从脑脊液(CSF)到脉络丛(CP)和其他脑组织的转移。所使用的化合物为布雷菲德菌素A,低钠人工CSF(aCSF),BCH,毛绿菌素和牛磺胆酸盐(TA)。将放射性标记的T4(125I-T4)连续灌注到CSF中,并使用体内脑室脑池灌注(V-C)技术在几个脑室中用参考分子14C-甘露醇和蓝色葡聚糖对其进行评估。灌注一小时后输注含有目标药物的aCSF。对照灌注一小时后,将药物独立应用于aCSF。有趣的是,在低钠或低BCH的情况下,与对照相比,125I-T4的回收率有所提高,同时T4清除率也随之提高。相反,布雷菲德菌素A,促绿素和TA对aCSF中评估的125I-T4的回收率和清除率没有显着影响。另一方面,与存在布雷菲德菌素A的对照组相比,对CP的125I-T4吸收提高了18倍。此外,仅低钠,BCH或Phloretin单独提高了125I-T4的吸收约3倍。折叠,而TA没有显示任何明显的影响。最后,125 I-T4的吸收和分布到其他脑区,包括室管膜区(ER)和尾状壳核(CAP)均明显高于对照组。我们的研究表明涉及125I-T4从CSF转移到CP和其他大脑区域的不同机制。这种转移可能暗示了钠依赖性机制,氨基酸“ L”系统或有机阴离子转运多肽(OATP)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号